Experts call for precision diagnosis and standardised neonatal protocols

The perinatology CME at Navi Mumbai brought together more than 100 obstetricians, pediatricians, and neonatologists

Oxford-ZEISS advances breakthrough live-cell imaging platform for next-gen drug discovery

The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners

Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies

The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio

Vir Biotechnology advances VIR-5500 into expansion trials in prostate cancer

Imagene AI teams up with Daiichi Sankyo to supercharge cancer drug development

A major push to sharpen the future of cancer treatment is underway

WHO unites 800+ institutions in historic global health push to prepare for next pandemic threat

Scientists at the forum warned of an increasingly volatile health landscape

Boehringer Ingelheim & BioNTech launch high-stakes lung cancer combo trial

BioNTech will supply pumitamig, a PD-L1/VEGF-A bispecific antibody co-developed with Bristol Myers Squibb, while Boehringer Ingelheim will act as the regulatory sponsor of a Phase Ib/II study

Thermo Fisher and Singapore’s PRECISE launch major proteomics push in 100,000-person study

The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation

India Pharma 2026 showcases sectoral transformation through four key plenary discussions

Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals

India must build its own agile biopharma innovation model: ICMR DG Dr Rajiv Bahl

At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace